Description: MOR Analytics, founded in 2019, is an innovative and evolving private company developing a Real World Evidence ("RWE") and Software as a Service ("SaaS") analytics platform designed to support the information requirements of constituents across the healthcare industry. The platform will enable life science companies, payers, providers, and regulators to better understand the value and efficacy of healthcare products and services while providing mission critical business insights into clients' products, services, customers and the dynamics of a rapidly changing marketplace. Management, administrators, physicians, patients and caregivers can, in turn, use the information to make informed business decisions and guide healthcare decision making. MOR has assembled one of the largest proprietary, de-identified patient-level RWE databases in the U.S. The MOR platform has been developed leveraging state-of-the-art technologies coupled with rigorous HIPAA standards.
Home Page: forian.com
FORA Technical Analysis
41 University Drive
Newtown,
PA
18940
United States
Phone:
267 225 6263
Officers
| Name | Title |
|---|---|
| Mr. Daniel J. Barton | CEO & Director |
| Mr. Michael Vesey | Chief Financial Officer |
| Mr. Edward Francis Spaniel Jr. | Exec. VP, Gen. Counsel & Sec. |
| Mr. Max C. Wygod | Co-Founder & Exec. Chairman |
| Mr. Adam H. Dublin | Co-Founder, Chief Strategy Officer & Director |
| Mr. Jason Holden | VP of Corp. Devel. |
| Mr. Mark J. Grove | VP of Sales |
| Rebecca Adams | VP of HR |
| Mr. Andrew Douglas | Chief Analytics Officer |
| Mr. David Terrell | BioTrack Chief Technology Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.6563 |
| Price-to-Sales TTM: | 2.7077 |
| IPO Date: | 2021-03-03 |
| Fiscal Year End: | December |
| Full Time Employees: | 138 |